Ann Kalita
Molecular Biology Consortium(US)
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Peptidase Inhibition and Analysis, Cancer-related Molecular Pathways
Most-Cited Works
- → Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer(1998)981 cited
- → Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically(1999)705 cited
- → MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo(2008)335 cited
- → Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia(2008)234 cited
- → Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors(2008)118 cited
- → Discovery of N-(2-Aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an Orally Active Histone Deacetylase Inhibitor(2008)108 cited
- → Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay(2008)100 cited
- Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors.(2002)
- → Development of Potential Antitumor Agents. Synthesis and Biological Evaluation of a New Set of Sulfonamide Derivatives as Histone Deacetylase Inhibitors(2003)71 cited
- → Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors(2007)35 cited